Literature DB >> 18704472

Vascular lesions of the vocal fold.

Kürşat Mustafa Gökcan1, Gürsel Dursun.   

Abstract

The aim of the study was to present symptoms, laryngological findings, clinical course, management modalities, and consequences of vascular lesions of vocal fold. This study examined 162 patients, the majority professional voice users, with vascular lesions regarding their presenting symptoms, laryngological findings, clinical courses and treatment results. The most common complaint was sudden hoarseness with hemorrhagic polyp. Microlaryngoscopic surgery was performed in 108 cases and the main indication of surgery was the presence of vocal fold mass or development of vocal polyp during clinical course. Cold microsurgery was utilized for removal of vocal fold masses and feeding vessels cauterized using low power, pulsed CO(2) laser. Acoustic analysis of patients revealed a significant improvement of jitter, shimmer and harmonics/noise ratio values after treatment. Depending on our clinical findings, we propose treatment algorithm where voice rest and behavioral therapy is the integral part and indications of surgery are individualized for each patient.

Entities:  

Mesh:

Year:  2008        PMID: 18704472     DOI: 10.1007/s00405-008-0792-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  13 in total

1.  Right posthemorrhagic polyp with vocal fold varices.

Authors:  Timothy Anderson; Mary Hawkshaw; Robert T Sataloff
Journal:  Ear Nose Throat J       Date:  2002-08       Impact factor: 1.697

Review 2.  Symptoms and findings of laryngopharyngeal reflux.

Authors:  Peter C Belafsky; Gregory N Postma; Milan R Amin; James A Koufman
Journal:  Ear Nose Throat J       Date:  2002-09       Impact factor: 1.697

Review 3.  Vocal fold masses.

Authors:  Kenneth W Altman
Journal:  Otolaryngol Clin North Am       Date:  2007-10       Impact factor: 3.346

4.  Finite element modeling of vocal fold vibration in normal phonation and hyperfunctional dysphonia: implications for the pathogenesis of vocal nodules.

Authors:  J J Jiang; C E Diaz; D G Hanson
Journal:  Ann Otol Rhinol Laryngol       Date:  1998-07       Impact factor: 1.547

5.  Vocal fold hemorrhage.

Authors:  J R Spiegel; R T Sataloff; M Hawkshaw; D C Rosen
Journal:  Ear Nose Throat J       Date:  1996-12       Impact factor: 1.697

6.  Ectasias and varices of the vocal fold: clearing the striking zone.

Authors:  I Hochman; R T Sataloff; R E Hillman; S M Zeitels
Journal:  Ann Otol Rhinol Laryngol       Date:  1999-01       Impact factor: 1.547

Review 7.  Vocal emergencies.

Authors:  Adam M Klein; Michael M Johns
Journal:  Otolaryngol Clin North Am       Date:  2007-10       Impact factor: 3.346

Review 8.  Vocal problems among teachers: a review of prevalence, causes, prevention, and treatment.

Authors:  J A Mattiske; J M Oates; K M Greenwood
Journal:  J Voice       Date:  1998-12       Impact factor: 2.009

9.  Clearing microvascular lesions of the true vocal fold with the KTP/532 laser.

Authors:  Ming-Wang Hsiung; Bor-Hwang Kang; Wan-Fu Su; Lu Pai; Hsing-Won Wang
Journal:  Ann Otol Rhinol Laryngol       Date:  2003-06       Impact factor: 1.547

10.  Microvascular lesions of the true vocal fold.

Authors:  G N Postma; M S Courey; R H Ossoff
Journal:  Ann Otol Rhinol Laryngol       Date:  1998-06       Impact factor: 1.547

View more
  2 in total

1.  The use of narrow band imaging for the detection of benign lesions of the larynx.

Authors:  Sebastian Dippold; Manfred Nusseck; Bernhard Richter; Matthias Echternach
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-08       Impact factor: 2.503

2.  Proposal for a descriptive guideline of vascular changes in lesions of the vocal folds by the committee on endoscopic laryngeal imaging of the European Laryngological Society.

Authors:  Christoph Arens; Cesare Piazza; Mario Andrea; Frederik G Dikkers; Robin E A Tjon Pian Gi; Susanne Voigt-Zimmermann; Giorgio Peretti
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-12-17       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.